Kim Sablich
Director/Miembro de la Junta en EIGER BIOPHARMACEUTICALS, INC. .
Fortuna: 6 M $ al 30/04/2024
Cargos activos de Kim Sablich
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
EIGER BIOPHARMACEUTICALS, INC. | Director/Miembro de la Junta | 23/04/2021 | - |
Independent Dir/Board Member | 23/04/2021 | - |
Historial de carrera de Kim Sablich
Antiguos cargos conocidos de Kim Sablich.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
JAZZ PHARMACEUTICALS PLC | Corporate Officer/Principal | 01/06/2020 | 31/12/2023 |
AllerGenis LLC
AllerGenis LLC Data Processing ServicesTechnology Services AllerGenis LLC specializes in detecting and managing life-threatening food allergies. AllerGenis is based in Hatfield, PA, and the CEO of the joint venture company is Jim Garner. The company develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. AllerGenis owns and operates a CLIA-certified laboratory and is amassing the world's largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes. The company was founded in 2017 through a collaboration between Genisphere and Hugh Sampson MD of the Icahn School of Medicine at Mount Sinai. | Director/Miembro de la Junta | 01/04/2018 | 01/04/2021 |
MYOVANT SCIENCES LTD. | Corporate Officer/Principal | 07/11/2018 | 11/05/2020 |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Corporate Officer/Principal | 01/12/2018 | 01/05/2020 |
GSK PLC | Corporate Officer/Principal | 01/10/2010 | 01/05/2018 |
Formación de Kim Sablich.
Denison University | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 6 |
Reino Unido | 3 |
Irlanda | 2 |
Operativa
Corporate Officer/Principal | 4 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 6 |
Consumer Services | 3 |
Technology Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
JAZZ PHARMACEUTICALS PLC | Health Technology |
GSK PLC | Health Technology |
EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Myovant Sciences Ltd.
Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Myovant Sciences, Inc. offers therapeutics for women's health and prostate cancer. The company is headquartered in New York, NY. | Health Technology |
AllerGenis LLC
AllerGenis LLC Data Processing ServicesTechnology Services AllerGenis LLC specializes in detecting and managing life-threatening food allergies. AllerGenis is based in Hatfield, PA, and the CEO of the joint venture company is Jim Garner. The company develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose, assess, and monitor patients with food allergies. AllerGenis owns and operates a CLIA-certified laboratory and is amassing the world's largest database of phenotypic patient data derived from epitope mapping, clinical history, and patient-reported outcomes. The company was founded in 2017 through a collaboration between Genisphere and Hugh Sampson MD of the Icahn School of Medicine at Mount Sinai. | Technology Services |
- Bolsa de valores
- Insiders
- Kim Sablich
- Experiencia